•
Oct 03, 2020

Flowers Foods Q3 2020 Earnings Report

Flowers Foods reported increased sales and net income in Q3 2020, driven by a favorable operating environment for its branded retail business.

Key Takeaways

Flowers Foods reported a 2.4% increase in sales to $989.7 million and a 2.3% increase in net income to $44.3 million for the third quarter of 2020. The company benefited from increased in-home eating and executed its portfolio strategy and supply chain optimization initiatives.

Sales increased 2.4% to $989.7 million.

Net income increased 2.3% to $44.3 million.

Adjusted EBITDA increased 22.4% to $116.4 million, representing 11.8% of sales.

Diluted EPS increased $0.01 to $0.21.

Total Revenue
$990M
Previous year: $967M
+2.4%
EPS
$0.29
Previous year: $0.22
+31.8%
Pricing/Mix Change
8.1%
Sales Volume Change
-5.7%
Gross Profit
$492M
Previous year: $458M
+7.5%
Cash and Equivalents
$326M
Previous year: $6.97M
+4575.7%
Free Cash Flow
$67M
Previous year: $46.8M
+43.0%
Total Assets
$3.39B
Previous year: $3.21B
+5.5%

Flowers Foods

Flowers Foods

Flowers Foods Revenue by Segment

Forward Guidance

For the 53-week Fiscal 2020, the Company Expects: Sales in the range of approximately $4.350 billion to $4.370 billion, representing growth of approximately 5.5% to 6.0%. Diluted EPS in the range of approximately $0.65 to $0.70. Adjusted diluted EPS in the range of approximately $1.23 to $1.28, adjusted for items affecting comparability, representing annual growth of approximately 28.1% to 33.3%.

Positive Outlook

  • Sales in the range of approximately $4.350 billion to $4.370 billion, representing growth of approximately 5.5% to 6.0%.
  • Diluted EPS in the range of approximately $0.65 to $0.70.
  • Adjusted diluted EPS in the range of approximately $1.23 to $1.28, adjusted for items affecting comparability, representing annual growth of approximately 28.1% to 33.3%.
  • Portfolio and supply chain optimization benefit in excess of $20 million.
  • Depreciation and amortization in the range of $140 million to $145 million.

Challenges Ahead

  • Net interest expense of approximately $11 million
  • An effective tax rate of approximately 24.0% to 24.5%
  • Weighted average diluted share count for the year of approximately 212.5 million shares
  • Capital expenditures for the year in the range of $85 million to $95 million
  • No specific negatives were mentioned.